Stockwatch. After Nycomed, next up?
This article was originally published in Scrip
As the first quarter 2011 earnings season dwindles to a close, the bigger draw this week was the announcement that Nycomed is to be acquired by Takeda for €9.6bn (scripintelligence.com, 19 May 2011). This is the second big ticket acquisition of a mid-sized specialty pharmaceutical company by a bigger acquirer in successive weeks. The first was Cephalon which is being acquired by Teva (scripintelligence.com, 6 May 2011).